Boston Scientific picks up EMcision
Boston Scientific (NYSE:BSX) said today that built out its biliary offering with the acquisition of endoscope maker EMcision for an undisclosed amount.
London- and Montreal-based EMcision makes the Habib EndoHPB probe, which is designed to coagulate tissue in the gastrointestinal tract in treating pancreaticobiliary cancers. Marlborough, Mass.-based Boston Scientific said the probe has 510(k) clearance from the FDA and CE Mark approval in the European Union.
“As we continue to search for ways to treat pancreaticobiliary cancers, we also seek to improve the quality of life for patients living with a cancer diagnosis ...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Oncology Wall Street Beat Boston Scientific emcision Source Type: news
Motus GI wins CE Mark for Pure-Vu system
Motus GI said today it won CE Mark approval in the European Union for its flagship Pure-Vu system designed to clean poorly-prepped colons during colonoscopies.
Approval was supported by positive results from a 47-patient European clinical study of the Pure-Vu system in cleaning poorly prepared colons, which showed an increase in the number of adequately cleansed patients from 19.1% at baseline to 100% after use.
“I believe the Pure-Vu System has tremendous potential to provide physicians with an easy-to-use device that enables a quality exam for patients, especially those who experience difficulty with the prep, and...
Source: Mass Device - March 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Regulatory/Compliance MOTUS GI Source Type: news
Three Rivers Medical wins CE Mark for Rio aneurysm embolization device
Three Rivers Medical said yesterday that it won CE Mark approval in the European Union back in October for its Rio embolization coil for treating brain aneurysms.
Mountain View, Calif.-based Three Rivers said it also treated the first 10 patients with the Rio device, which is also CE Marked for peripheral embolizations. The company said it plans to go to market via distributor in territories that recognize the mark.
“The use of embolization coils to treat intracranial aneurysms continues to be the global gold standard for therapeutic neurovascular interventions and is proven to be safe and effective for both rupture...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Neurological Regulatory/Compliance Three Rivers Medical Source Type: news
Motus GI closes $18m IPO
Motus GI last week closed an initial public offering worth $18 million for its Pure-Vu system for intra-colonoscopy cleaning.
Fort Lauderdale-based Motus said it plans to use the proceeds to commercialize Pure-Vu and for R&D, among other things. The company said it sold 3.5 million shares at $5 apiece, grossing $17.5 million, and also granted a 30-day over-allotment of 525,000 shares to its underwriters.
Motus GI originally hoped to raise $28.8 million in the IPO when it announced it in early January. When the company set its terms for the offering, it had a midpoint of nearly $26 million. The stock, which trades o...
Source: Mass Device - February 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Funding Roundup Initial Public Offering (IPO) Wall Street Beat MOTUS GI Source Type: news
Orthofix launches RCStim rotator cuff repair trial
Orthofix (NSDQ:OFIX) said today it launched a study looking to evaluate the use of pulsed electromagnetic field technology with the company’s RCStim device as adjunctive treatment to the surgical repair of rotator cuff tears.
The 538-patient study, which has begun enrollment, will evaluate the safety and effectiveness of PEMF technology designed to promote bone growth and whether it can reduce the rate of repaired tendons being subsequently torn, as well as overall improvement in patient outcomes.
“Arthroscopic repair of rotator cuff tears can improve pain and functional use of the shoulder but a continuing ch...
Source: Mass Device - February 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Orthopedics Orthofix Source Type: news
17 black innovators who made medtech better
From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements.
Here are 17 black innovators who have made discoveries and invented devices to make medtech better.
Next >>
The post 17 black innovators who made medtech better appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blood Management Cardiac Assist Devices Cardiac Implants Cardiovascular Diagnostics Endoscopic / Arthroscopic Hospital Care Laboratory Instruments/Laboratory Supplies Oncology Pharmaceuticals Research & Development American Red Cross Source Type: news
Pentax Medical recalls ED-3490TK duodenoscopes
Hoya‘s Pentax Medical is recalling its ED-3490TK duodenoscopes looking to replace parts of the scopes to prevent leakage of patient fluids into the device, according to an FDA release.
The company is looking to replace the forceps elevator mechanism, o-ring seal and distal end covering to prevent leakage of fluids into the closed elevator channel and under the distal cap, according to the FDA release.
The federal watchdog said it cleared updated design and labeling for the duodenoscope, and that it is closely monitoring the association between so called ‘superbug’ outbreaks and the use of reprocessed endoscopes.
Pe...
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Recalls Pentax Medical Source Type: news
Motus GI sets terms for $26m IPO
Motus GI yesterday set the range for its pending initial public offering, which at the midpoint would fetch nearly $26 million.
Last month the Israeli company, which makes the Pure-Vu intra-colonoscopy cleaning system, registered the IPO at roughly $28.8 million. Motus GI won FDA clearance for the device in September 2016.
Yesterday Motus said it plans to float 4.25 million shares at $5 to $7 apiece, for a range of about $21.3 million to nearly $29.8 million.
The company said it plans to list on the NASDAQ exchange under the symbol “MOTS,” noting that Piper Jaffray and Oppenheimer are acting as joint bookrunn...
Source: Mass Device - February 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Funding Roundup Wall Street Beat MOTUS GI Source Type: news
13th Hanover Arthroscopy and Arthroplasty Course
2 days only shoulder. Live surgeries. Live clinical examination. Live indication for surgeryCongress language German (simultaneous translation into English) (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - January 24, 2018 Category: Orthopaedics Tags: Featured Meetings Events Source Type: news
Clinical outcomes, return to sports, and patient satisfaction after anterior cruciate ligament reconstruction in young and middle-aged patients in an asian population-a 2-year follow-up study - Tay KS, Tan AHC.
PURPOSE: To compare the clinical outcomes of arthroscopic anterior cruciate ligament (ACL) reconstruction in young and middle-aged Asians. METHODS: A retrospective study was performed using prospectively collected data from a tertiary institution A... (Source: SafetyLit)
Source: SafetyLit - January 9, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Motus GI announces plans for $29m IPO
Motus GI said this week it intends to hold an initial public offering to raise approximately $28.8 million, according to an SEC filing.
The company developed and produces the Pure-Vu cleaning system which is designed to be used with a standard colonoscope to perform intra-procedural cleaning of poorly prepared colons.
Motus GI won FDA clearance for the device in September 2016.
The Israel-based company said it plans to list on the NASDAQ under the ticker symbol ‘MOTS’, and said that Piper Jaffray and Oppenheimer are acting as book runners for the offering, according to the SEC filing.
The company has not yet released ...
Source: Mass Device - January 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Initial Public Offering (IPO) MOTUS GI Source Type: news
Attune Medical wins 510(k) clearance for drug-delivery model of EnsoETM esophageal device
Attune Medical said today that it won 510(k) clearance from the FDA for a new model of its EnsoETM device capable of administering tube feeds or medication while regulating a patient’s temperature through the esophagus.
The newly-approved model allows clinicians to maintain a patient’s core temperature while simultaneously administering fluids, eliminating the need for a separate feeding tube.
Get the full story at our sister site, Drug Delivery Business News.
The post Attune Medical wins 510(k) clearance for drug-delivery model of EnsoETM esophageal device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: 510(k) Drug-Device Combinations Endoscopic / Arthroscopic Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance attunemedical Source Type: news
New Surgical Option for Serious Rotator Cuff Tears
Treatment TermsOrthopaedicsRotator Cuff TearsShoulder pain and injuries
Overview
If you have a severe rotator cuff tear that can ’t be mended, or if a previous repair didn’t bring relief, superior capsule reconstruction may help.
Content Blocks
Header
About Rotator Cuff Tears and Repairs
ContentYour shoulder is a ball-and-socket joint. The rotator cuff is a group of tendons and muscles that help keep the ball at the top of your upper-arm bone centered in your shoulder socket. It also helps you lift and rotate your arm.When your rotator cuff tears -- either from a sudden injury or long-term wear-and-tear -- ...
Source: dukehealth.org: Duke Health News - January 5, 2018 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news
High rate of return to cycling after hip arthroscopy for femoroacetabular impingement syndrome - Frank RM, Ukwuani G, Clapp I, Chahla J, Nho SJ.
BACKGROUND: Femoroacetabular impingement syndrome (FAIS) is most commonly diagnosed in athletes who sustain repetitive flexion and rotational loading to their hip. The purpose of this study was to evaluate a patient's ability to return to cycling after hip... (Source: SafetyLit)
Source: SafetyLit - December 29, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Arthroscopy in Pigmented Villonodular Synovitis of the Ankle Arthroscopy in Pigmented Villonodular Synovitis of the Ankle
Learn more about arthroscopically assisted treatment for pigmented villonodular synovitis in the ankle or subtalar joint.Current Orthopaedic Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 21, 2017 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
